Pricing Log in Create free account

Precision BioSciences, Inc. (DTIL) vs Fulcrum Therapeutics, Inc. (FULC)

Precision BioSciences, Inc. and Fulcrum Therapeutics, Inc. are both Biotechnology companies. Precision BioSciences, Inc. and Fulcrum Therapeutics, Inc. are of similar size ($280.8M and $275.7M). Fulcrum Therapeutics, Inc. grew revenue faster over the last twelve months: 1,939.8% against −11.9%. Across the 12 metrics below, Fulcrum Therapeutics, Inc. leads on 8 and Precision BioSciences, Inc. on 4.

Valuation

Metric DTIL FULC Biotechnology median
P/E n/m n/m 10.60
P/S 6.54 3.43 9.40
P/B 5.70 0.91 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.38 0.66
EV/Sales 5.22 (0.44) 9.02
Earnings yield (11.41%) (32.61%) (32.88%)
Free cash flow yield (17.77%) (23.22%) (23.13%)

Profitability

Metric DTIL FULC Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (112.69%) (32.38%) (51.96%)
Return on assets (36.04%) (30.75%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DTIL FULC Biotechnology median
Revenue growth (TTM) (11.87%) 1,939.80% 6.76%
EPS growth (last fiscal year) (442.31%) (637.50%) 29.88%
Revenue growth, 5-year CAGR 7.13% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL FULC Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 10.47 31.35 4.97
Net debt to EBITDA 1.86 4.23 1.01

Dividend

Metric DTIL FULC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DTIL FULC Biotechnology median
Market cap 275.73m 280.77m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack